FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2773164014> ?p ?o ?g. }

• W2773164014 endingPage "870" @default.
• W2773164014 startingPage "865" @default.
• W2773164014 abstract "Both EUCAST and CLSI recommend broth microdilution (BMD) for antimicrobial susceptibility testing of colistin, but BMD is rarely used in routine microbiology laboratories. The objective of this study was to evaluate five commercially available BMD products and two brands of gradient tests for colistin MIC determination using BMD according to ISO standard 20776-1 as reference.Colistin MIC determination was performed according to the manufacturer's instructions on five commercially available BMD products (Sensititre, MICRONAUT-S, MICRONAUT MIC-Strip, SensiTest, and UMIC) and two gradient tests (Etest and MIC Test Strip). Colistin reference MICs were determined using frozen panels according to ISO standard 20776-1. An international collection of Gram-negative bacteria (n=75) with varying levels of colistin susceptibility was tested.The colistin BMD products correlated well with reference tests, in particular for Sensititre and the two MICRONAUT products (essential agreement ≥96%: 66/69 (96%, CI 88-99%), 72/75 (96%, CI 88-99%) and 74/75 (99%, CI 92-100%)). The results were somewhat poorer for the BMD products SensiTest and UMIC: EA 88% (51/58, CI 77-95%) and 82% (61/74, CI 72-89%), respectively), and considerably poorer for the gradient tests (EA 43-71% depending on gradient test and Mueller-Hinton agar manufacturer). The gradient tests generally underestimated colistin MICs, resulting in a significant number of false susceptible results (9-18 of total 75 tests, compared with 1-3 for the BMD products).Based on the results of this study, we advise laboratories not to trust gradient tests for colistin susceptibility testing and to use broth microdilution methods for this purpose. There are several commercial broth microdilution tests available and in principle they perform well." @default.
• W2773164014 created "2017-12-22" @default.
• W2773164014 creator A5015188114 @default.
• W2773164014 creator A5024736923 @default.
• W2773164014 creator A5072265483 @default.
• W2773164014 creator A5081483425 @default.
• W2773164014 date "2018-08-01" @default.
• W2773164014 modified "2023-10-12" @default.
• W2773164014 title "Antimicrobial susceptibility testing of colistin – evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp." @default.
• W2773164014 cites W119206671 @default.
• W2773164014 cites W1991842673 @default.
• W2773164014 cites W2000167748 @default.
• W2773164014 cites W2062347073 @default.
• W2773164014 cites W2108938392 @default.
• W2773164014 cites W2626840811 @default.
• W2773164014 doi "https://doi.org/10.1016/j.cmi.2017.11.020" @default.
• W2773164014 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29221995" @default.
• W2773164014 hasPublicationYear "2018" @default.
• W2773164014 type Work @default.
• W2773164014 sameAs 2773164014 @default.
• W2773164014 citedByCount "194" @default.
• W2773164014 countsByYear W27731640142018 @default.
• W2773164014 countsByYear W27731640142019 @default.
• W2773164014 countsByYear W27731640142020 @default.
• W2773164014 countsByYear W27731640142021 @default.
• W2773164014 countsByYear W27731640142022 @default.
• W2773164014 countsByYear W27731640142023 @default.
• W2773164014 crossrefType "journal-article" @default.
• W2773164014 hasAuthorship W2773164014A5015188114 @default.
• W2773164014 hasAuthorship W2773164014A5024736923 @default.
• W2773164014 hasAuthorship W2773164014A5072265483 @default.
• W2773164014 hasAuthorship W2773164014A5081483425 @default.
• W2773164014 hasBestOaLocation W27731640141 @default.
• W2773164014 hasConcept C104317684 @default.
• W2773164014 hasConcept C176947019 @default.
• W2773164014 hasConcept C2777058267 @default.
• W2773164014 hasConcept C2779259085 @default.
• W2773164014 hasConcept C2780950330 @default.
• W2773164014 hasConcept C4937899 @default.
• W2773164014 hasConcept C547475151 @default.
• W2773164014 hasConcept C55493867 @default.
• W2773164014 hasConcept C71924100 @default.
• W2773164014 hasConcept C81396022 @default.
• W2773164014 hasConcept C86803240 @default.
• W2773164014 hasConcept C89423630 @default.
• W2773164014 hasConceptScore W2773164014C104317684 @default.
• W2773164014 hasConceptScore W2773164014C176947019 @default.
• W2773164014 hasConceptScore W2773164014C2777058267 @default.
• W2773164014 hasConceptScore W2773164014C2779259085 @default.
• W2773164014 hasConceptScore W2773164014C2780950330 @default.
• W2773164014 hasConceptScore W2773164014C4937899 @default.
• W2773164014 hasConceptScore W2773164014C547475151 @default.
• W2773164014 hasConceptScore W2773164014C55493867 @default.
• W2773164014 hasConceptScore W2773164014C71924100 @default.
• W2773164014 hasConceptScore W2773164014C81396022 @default.
• W2773164014 hasConceptScore W2773164014C86803240 @default.
• W2773164014 hasConceptScore W2773164014C89423630 @default.
• W2773164014 hasFunder F4320320916 @default.
• W2773164014 hasIssue "8" @default.
• W2773164014 hasLocation W27731640141 @default.
• W2773164014 hasLocation W27731640142 @default.
• W2773164014 hasOpenAccess W2773164014 @default.
• W2773164014 hasPrimaryLocation W27731640141 @default.
• W2773164014 hasRelatedWork W1994169691 @default.
• W2773164014 hasRelatedWork W2108938392 @default.
• W2773164014 hasRelatedWork W2118284620 @default.
• W2773164014 hasRelatedWork W2129734287 @default.
• W2773164014 hasRelatedWork W2344686847 @default.
• W2773164014 hasRelatedWork W2744408422 @default.
• W2773164014 hasRelatedWork W2773164014 @default.
• W2773164014 hasRelatedWork W2885160863 @default.
• W2773164014 hasRelatedWork W3104300325 @default.
• W2773164014 hasRelatedWork W4237700847 @default.
• W2773164014 hasVolume "24" @default.
• W2773164014 isParatext "false" @default.
• W2773164014 isRetracted "false" @default.
• W2773164014 magId "2773164014" @default.
• W2773164014 workType "article" @default.